Dashboard
Manage Tickers

RVTY REVVITY, INC.

NYSE perkinelmer.com


$ 93.58 $ 2.57 (2.82 %)    

Friday, 31-Oct-2025 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 93.59
$ 90.34
$ 89.88 x 4
$ 97.00 x 33
$ 90.34 - $ 94.32
$ 81.30 - $ 129.14
1,163,681
na
10.86B
$ 1.04
$ 38.09
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-29-2025 10-Q
2 05-06-2025 03-30-2025 10-Q
3 02-25-2025 12-29-2024 10-K
4 11-06-2024 09-29-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 10-01-2023 10-Q
9 08-09-2023 07-02-2023 10-Q
10 05-12-2023 04-02-2023 10-Q
11 03-01-2023 01-01-2023 10-K
12 11-14-2022 10-02-2022 10-Q
13 08-09-2022 07-03-2022 10-Q
14 05-10-2022 04-03-2022 10-Q
15 03-03-2022 01-02-2022 10-K
16 11-09-2021 10-03-2021 10-Q
17 08-10-2021 07-04-2021 10-Q
18 05-11-2021 04-04-2021 10-Q
19 03-02-2021 01-03-2021 10-K
20 11-10-2020 10-04-2020 10-Q
21 08-11-2020 07-05-2020 10-Q
22 05-12-2020 04-05-2020 10-Q
23 02-25-2020 12-29-2019 10-K
24 11-05-2019 09-29-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-30-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 07-01-2018 10-Q
30 05-08-2018 04-01-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-07-2017 10-01-2017 10-Q
33 08-08-2017 07-02-2017 10-Q
34 05-09-2017 04-02-2017 10-Q
35 02-28-2017 01-01-2017 10-K
36 11-08-2016 10-02-2016 10-Q
37 08-09-2016 07-03-2016 10-Q
38 05-10-2016 04-03-2016 10-Q
39 03-01-2016 01-03-2016 10-K
40 11-10-2015 10-04-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

revvity-analysts-increase-their-forecasts-after-q3-earnings
Revvity Analysts Increase Their Forecasts ...
10/28/2025 13:32:12

barclays-maintains-overweight-on-revvity-raises-price-target-to-105
Barclays Maintains Overweight on Revvity, ...
10/28/2025 13:24:07

Barclays analyst Luke Sergott maintains Revvity (NYSE:RVTY) with a Overweight and raises the price target from $100 to $105.

baird-maintains-outperform-on-revvity-raises-price-target-to-123
Baird Maintains Outperform on Revvity, Rai...
10/28/2025 12:20:19

Baird analyst Catherine Ramsey maintains Revvity (NYSE:RVTY) with a Outperform and raises the price target from $122 to $123.

tech-stocks-rally-gold-tumbles-on-us-china-trade-progress-whats-moving-markets-monday
Tech Stocks Rally, Gold Tumbles On US-Chin...
10/27/2025 17:03:17

Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of s...

revvity-lifts-profit-outlook-launches-1-billion-buyback-plan
Revvity Lifts Profit Outlook, Launches $1 ...
10/27/2025 13:34:31

Revvity Inc. (NYSE: RVTY) announced mixed Q3 results, beating EPS but missing revenue estimates, leading to a decline in stock ...

revvity-board-authorized-new-1b-share-repurchase-program
Revvity Board Authorized New $1B Share Rep...
10/27/2025 10:41:01

revvity-raises-fy2025-adj-eps-guidance-from-485-495-to-490-500-vs-486-est-widens-fy2025-sales-guidance-from-2840b-2880b-to-2830b-2880b-vs-2849b-est
Revvity Raises FY2025 Adj EPS Guidance fro...
10/27/2025 10:01:14

Revvity (NYSE:RVTY) raises FY2025 Adj EPS guidance from $4.85-$4.95 to $4.90-$5.00 vs $4.86 analyst estimate. Widens FY2025 sal...

revvity-q3-adj-eps-118-beats-114-estimate-sales-698949m-miss-700457m-estimate
Revvity Q3 Adj. EPS $1.18 Beats $1.14 Esti...
10/27/2025 10:00:37

Revvity (NYSE:RVTY) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.14 by 3.78 p...

earnings-scheduled-for-october-27-2025
Earnings Scheduled For October 27, 2025
10/27/2025 08:32:18

Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterly earnings at $0.54 per sha...

revvity-earnings-preview
Revvity Earnings Preview
10/24/2025 14:02:25

whats-driving-the-market-sentiment-around-revvity-inc
What's Driving the Market Sentiment Around...
10/21/2025 13:00:59

guggenheim-initiates-coverage-on-revvity-with-neutral-rating
Guggenheim Initiates Coverage On Revvity w...
10/16/2025 12:52:29

Guggenheim analyst Subbu Nambi initiates coverage on Revvity (NYSE:RVTY) with a Neutral rating.

evercore-isi-group-maintains-outperform-on-revvity-lowers-price-target-to-106
Evercore ISI Group Maintains Outperform on...
10/07/2025 17:52:41

Evercore ISI Group analyst Vijay Kumar maintains Revvity (NYSE:RVTY) with a Outperform and lowers the price target from $108...

what-analysts-are-saying-about-revvity-stock
What Analysts Are Saying About Revvity Stock
10/02/2025 14:01:25

Core News & Articles
Revvity Expands Type 1 Diabetes Portfolio ...
10/02/2025 12:04:49

Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease scr...

b-of-a-securities-maintains-buy-on-revvity-lowers-price-target-to-99
B of A Securities Maintains Buy on Revvity...
09/22/2025 18:07:27

B of A Securities analyst Michael Ryskin maintains Revvity (NYSE:RVTY) with a Buy and lowers the price target from $110 to $99.

is-revvity-gaining-or-losing-market-support
Is Revvity Gaining or Losing Market Support?
09/10/2025 17:00:47

alphabet-apple-fuel-tech-rebound-gold-defies-gravity-whats-moving-markets-wednesday
Alphabet, Apple Fuel Tech Rebound, Gold De...
09/03/2025 18:09:52

Wall Street staged a tentative rebound on Wednesday after two straight sessions of heavy tech losses, as rallies in Alphabet Inc.

revvity-unveils-phsense-reagents-to-advance-internalization-studies-in-drug-discovery
Revvity Unveils pHSense Reagents To Advanc...
08/06/2025 12:13:04

Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR a...

a-glimpse-into-the-expert-outlook-on-revvity-through-5-analysts
A Glimpse Into The Expert Outlook On Revvi...
07/29/2025 14:01:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION